Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 43-49 , January 2008

Long-Term Outcome after Bone Marrow Transplantation for Aplastic Anemia Using Cyclophosphamide and Total Lymphoid Irradiation as Conditioning Regimen

  • Yoshihiro Inamoto

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • Corresponding Author InformationCorrespondence and reprint requests: Yoshihiro Inamoto, MD, Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8560, Japan.
    • ,
  • Ritsuro Suzuki

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Yachiyo Kuwatsuka

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Takahiko Yasuda

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Taro Takahashi

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Akane Tsujimura

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Kyoko Sugimoto

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Taku Oba

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Seitaro Terakura

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Yoshiko Atsuta

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Makoto Murata

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Masafumi Ito

      Affiliations

    • Department of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Yoshihisa Kodera

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
    • ,
  • Koichi Miyamura

      Affiliations

    • Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

Received 15 June 2007 ,Accepted 16 September 2007.

References 

  1. Camitta BM, Thomas ED, Nathan DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood. 1979;53:504–514
  2. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. 1999;341:14–21
  3. Socie G, Henry-Amar M, Bacigalupo A, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993;329:1152–1157
  4. Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood. 2000;95:1931–1934
  5. Thomas ED, Storb R, Fefer A, et al. Aplastic anaemia treated by marrow transplantation. Lancet. 1972;1:284–289
  6. Champlin RE, Horowitz MM, van Bekkum DW, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood. 1989;73:606–613
  7. Sanders JE. The impact of marrow transplant preparative regimens on subsequent growth and development. The Seattle Marrow Transplant Team. Semin Hematol. 1991;28:244–249
  8. Gluckman E, Horowitz MM, Champlin RE, et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood. 1992;79:269–275
  9. Storb R, Etzioni R, Anasetti C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood. 1994;84:941–949
  10. Kojima S. High incidence of graft rejection in children with severe aplastic anemia preconditioned with cyclophosphamide and antithymocyte globulin regimen. Blood. 2001;98(Suppl 2):376b
  11. Abdelkefi A, Ben Othman T, Ladeb S, et al. Bone marrow transplantation for patients with acquired severe aplastic anemia using cyclophosphamide and antithymocyte globulin: the experience from a single center. Hematol J. 2003;4:208–213
  12. Bhatia S, Ramsay NK, Steinbuch M, et al. Malignant neoplasms following bone marrow transplantation. Blood. 1996;87:3633–3639
  13. Ramsay NK, Kim T, Nesbit ME, et al. Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood. 1980;55:344–346
  14. Miyamura K, Kojima S, Takeyama K, et al. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia. Bone Marrow Transplant. 1988;3:457–461
  15. Murata M, Muramoto H, Kojima Y, et al. Hepatic injury localized to the field of total lymphoid irradiation. Bone Marrow Transplant. 1997;20:897–899
  16. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825–828
  17. Sullivan KM, Agura E, Anasetti C, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991;28:250–259
  18. Hows JM, Marsh JC, Yin JL, et al. Bone marrow transplantation for severe aplastic anaemia using cyclosporin: long-term follow-up. Bone Marrow Transplant. 1989;4:11–16
  19. Gaziev D, Giardini C, Galimberti M, et al. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center. Bone Marrow Transplant. 1999;24:253–257
  20. Champlin RE, Ho WG, Nimer SD, et al. Bone marrow transplantation for severe aplastic anemia: effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy. Transplantation. 1990;49:720–724
  21. Novitzky N, Thomas V, Stubbings H, et al. Radiotherapy-based conditioning is effective immunosuppression for patients undergoing transplantation with T-cell–depleted stem cell grafts for severe aplasia. Cytotherapy. 2004;6:450–456
  22. Hows JM, Yin JL, Marsh J, et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood. 1986;68:1322–1328
  23. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993;328:593–602
  24. Bacigalupo A, Hows J, Gordon-Smith EC, et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. Bone Marrow Transplant. 1988;3:531–535
  25. Kahl C, Leisenring W, Deeg HJ, et al. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol. 2005;130:747–751
  26. Storb R, Blume KG, O'Donnell MR, et al. Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant. 2001;7:39–44
  27. Champlin RE, Perez WS, Passweg JR, et al. Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood. 2007;109:4582–4585
  28. Bacigalupo A, Locatelli F, Lanino E, et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant. 2005;36:947–950
  29. Bitan M, Or R, Shapira MY, et al. Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors. Biol Blood Marrow Transplant. 2006;12:712–718
  30. Srinivasan R, Takahashi Y, McCoy JP, et al. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol. 2006;133:305–314
  31. Margolis DA, Casper JT. Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia. Semin Hematol. 2000;37:43–55
  32. Deeg HJ, O'Donnell M, Tolar J, et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood. 2006;108:1485–1491
  33. Kojima S, Matsuyama T, Kato S, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood. 2002;100:799–803
  34. Ades L, Mary JY, Robin M, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 2004;103:2490–2497
  35. Soule BP, Simone NL, Savani BN, et al. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant. 2007;40:573–578
  36. Deeg HJ, Leisenring W, Storb R, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood. 1998;91:3637–3645
  37. Lowsky R, Takahashi T, Liu YP, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med. 2005;353:1321–1331
  38. Socie G, Henry-Amar M, Cosset JM, et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood. 1991;78:277–279
  39. Deeg HJ, Socie G, Schoch G, et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood. 1996;87:386–392

PII: S1083-8791(07)00462-4

doi: 10.1016/j.bbmt.2007.06.015

Biology of Blood and Marrow Transplantation
Volume 14, Issue 1 , Pages 43-49 , January 2008

Article Tools

* Image Usage & Resolution